Dutch vs Moderna

Side-by-side comparison of AI visibility scores, market position, and capabilities

Moderna leads in AI visibility (90 vs 35)
Dutch logo

Dutch

EmergingHealthTech

Pet Telehealth

San Francisco veterinary telehealth platform for pet behavioral and chronic conditions; licensed vets prescribe FDA-approved medications shipped directly to pet owners without clinic visits.

AI VisibilityBeta
Overall Score
D35
Category Rank
#556 of 596
AI Consensus
77%
Trend
stable
Per Platform
ChatGPT
37
Perplexity
39
Gemini
36

About

Dutch is a San Francisco-based online veterinary platform that specializes in diagnosing and treating pet behavioral and chronic conditions — including anxiety, allergies, skin conditions, and pain management — entirely through telehealth, with licensed veterinarians able to prescribe FDA-approved medications shipped directly to pet owners' homes. The platform addresses a specific gap in traditional veterinary care: behavioral issues like separation anxiety, noise phobias, and aggression that benefit more from ongoing medication management and coaching than from in-person visits. Dutch's veterinarians conduct intake assessments, recommend treatment plans, write prescriptions, and provide follow-up check-ins through the platform's video and messaging interface.

Full profile
Moderna logo

Moderna

LeaderHealthcare Tech

Enterprise

mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.

AI VisibilityBeta
Overall Score
A90
Category Rank
#2 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
92
Perplexity
93
Gemini
89

About

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.

Full profile

AI Visibility Head-to-Head

35
Overall Score
90
#556
Category Rank
#2
77
AI Consensus
83
stable
Trend
stable
37
ChatGPT
92
39
Perplexity
93
36
Gemini
89
30
Claude
96
32
Grok
95

Key Details

Category
Pet Telehealth
Enterprise
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Dutch
Pet Telehealth

Integrations

Only Moderna
Moderna is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.